Coronary Artery Bypass Grafts (CABG) Market (Updated Version Available)

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
Increase in incidence of cardiovascular diseases due to stress, obesity, sedentary lifestyle, and unhealthy habits are factor are likely to fuel the global coronary artery bypass graft market from 2018 to 2024. Increase in adoption of endoscopic surgeries, surge in incidence of cardiovascular diseases, demographic changes, rise in complications such as obesity and stress due to sedentary lifestyle and aging population, and growth in medical tourism drive the global coronary artery bypass graft market. However, lack of regulatory approvals, rise in cardiac complications after CABG, and high cost of surgery are major factors restraining the global coronary artery bypass graft market.
North America enjoys largest revenue market share in the world, with a revenue market share nearly 38.2% in 2018. Following North America, Europe is the second largest place with the revenue market share of 34.2%. Improved health care infrastructure and rise in awareness regarding cardiovascular diseases and its treatment drive the market in Europe and North America. The countries of rest of the world have a great potential for coronary artery bypass grafts market due to increasing incidence of cardiovascular diseases and also due to advancement in the technology.
Market competition is intense. Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

The Global Coronary Artery Bypass Grafts (CABG) Market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 - 2026.
It also includes Market size and forecast by each application segment in terms of volume for the period 2021-2026.
In the global Coronary Artery Bypass Grafts (CABG) Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.

In Market segmentation by manufacturers, the report covers the following companies-
Medtronic
Getinge Group
LivaNova
Terumo
Boston Scientific
Stryker
Edwards Lifesciences
Genesee Biomedical
Karl Storz GmbH

In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

In Market segmentation by types :
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
In Market segmentation by applications :
Traditional CABG
Nontraditional CABG

The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Coronary Artery Bypass Grafts (CABG) Market for the forecast period 2020 - 2026?
• What are the driving forces in the Coronary Artery Bypass Grafts (CABG) Market for the forecast period 2020 - 2026?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Coronary Artery Bypass Grafts (CABG) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players?